This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Kind Pharmaceutical. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Danyan Gu: Innovator in Indolizine Derivatives
Introduction
Danyan Gu is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of medicinal chemistry, particularly through his work on indolizine derivatives. With a total of 4 patents to his name, Gu continues to push the boundaries of innovation in medicine.
Latest Patents
One of Gu's latest patents focuses on indolizine derivatives and their application in medicine. This invention discloses novel substituted indolizine derivatives of formula I, which may include isotopically labeled compounds, optical isomers, geometric isomers, tautomers, or a mixture of various isomers. Additionally, the invention covers pharmaceutically acceptable salts and prodrugs of these compounds, emphasizing their potential use in medical applications.
Career Highlights
Danyan Gu is currently associated with Kind Pharmaceutical, where he applies his expertise in medicinal chemistry. His work has been instrumental in developing new therapeutic compounds that could lead to advancements in medical treatments.
Collaborations
Gu collaborates with notable colleagues, including Dong Liu and Dongdong Chen, who contribute to his research and development efforts. Their combined expertise enhances the innovative potential of their projects.
Conclusion
Danyan Gu's work on indolizine derivatives showcases his commitment to advancing medical science through innovation. His contributions are paving the way for new therapeutic options in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile